<IPO>HENGRUI PHARMA Clears HK Listing Hearing, Rumored to Pool Min. US$2B
A-share HENGRUI PHARMA (600276.SH) passed the hearing for listing in Hong Kong, with Morgan Stan...
A-share HENGRUI PHARMA (600276.SH) passed the hearing for listing in Hong Kong, with Morgan Stanley, Citi and Huatai International as co-sponsors.
The company would raise at least US$2 billion in Hong Kong, according to earlier market hearsay.
Based on the company's announcement at the end of April, it had received a notification from the China Securities Regulatory Commission (CSRC) of its intention to issue no more than 815 million H shares.
(A Shares quote is delayed for at least 15 mins.)
Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.
